Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis

Journal of Virology

Volumn 84, Issue 2, 2010, Pages 907-917

  Lamontagne, Jason ^b   Pinkerton, Mark ^a,c   Block, Timothy M ^a,b   Lu, Xuanyong ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BARUCH S BLUMBERG INSTITUTE   (United States)

^c Delaware Valley College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CELL PROTEIN; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC HEPATITIS; CONTROLLED STUDY; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HYPOTHESIS; LIVER CANCER; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRUS REPLICATION;

APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; KIDNEY; SERINE PROTEASES; UP-REGULATION; VIRUS REPLICATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 73849109817     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01249-09     Document Type: Article

References (45)

1. Abate, A., and H. Schroder. 1998. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-[kappa]B. Life Sci. 62:1081-1088.
2. Beresford, P. J., D. Zhang, D. Y. Oh, Z. Fan, E. L. Greer, M. L. Russo, M. Jaju, and J. Lieberman. 2001. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J. Biol. Chem. 276:43285-43293.
3. Chisari, F. V. 1997. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 99:1472-1477.
4. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
5. de Bruin, E. C., D. Meersma, J. de Wilde, I. den Otter, E. M. Schipper, J. P. Medema, and L. T. Peltenburg. 2003. A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ. 10:1204-1212.
6. Egger, L., J. Schneider, C. Rheme, M. Tapernoux, J. Hacki, and C. Borner. 2003. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ. 10:1188-1203.
7. Giannini, C., and C. Brechot. 2003. Hepatitis C virus biology. Cell Death Differ. 10(Suppl. 1):S27-S38.
8. Graf, R., and D. Bimmler. 2006. Biochemistry and biology of SPINK-PSTI and monitor peptide. Endocrinol. Metab. Clin. N. Am. 35:333-343.
9. Greene, L. J. 1975. Pancreatic exocrine secretory proteins. J. Surg. Oncol. 7:151-154.
10. Greene, L. J., M. H. Pubols, and D. C. Bartelt. 1976. Human pancreatic secretory trypsin inhibitor. Methods Enzymol. 45:813-825.
11. Gu, B., A. T. Gates, O. Isken, S. E. Behrens, and R. T. Sarisky. 2003. Replication studies using genotype 1a subgenomic hepatitis C virus replicons. J. Virol. 77:5352-5359.
12. Guicciardi, M. E., and G. J. Gores. 2005. Apoptosis: a mechanism of acute and chronic liver injury. Gut 54:1024-1033.
13. Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1:23-61.
14. Guo, J.-T., V. V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75:8516-8523.
15. Guo, Y., H. Guo, L. Zhang, H. Xie, X. Zhao, F. Wang, Z. Li, Y. Wang, S. Ma, J. Tao, W. Wang, Y. Zhou, W. Yang, and J. Cheng. 2005. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J. Virol. 79:14392-14403.
16. Higashiyama, M., T. Monden, N. Tomita, M. Murotani, Y. Kawasaki, H. Morimoto, A. Murata, T. Shimano, M. Ogawa, and T. Mori. 1990. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer. Br. J. Cancer 62:954-958.
17. Hofmann, W. P., E. Herrmann, C. Sarrazin, and S. Zeuzem. 2008. Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms. Liver Int. 28:1332-1343.
18. Kerr, J. F., C. M. Winterford, and B. V. Harmon. 1994. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2026.
19. Lee, Y. C., H. W. Pan, S. Y. Peng, P. L. Lai, W. S. Kuo, Y. H. Ou, and H. C. Hsu. 2007. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur. J. Cancer 43:736-744.
20. Lieberman, J. 2003. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3:361-370.
21. Lu, X., and T. Block. 2004. Study of the early steps of the hepatitis B virus life cycle. Int. J. Med. Sci. 1:21-33.
22. Lu, X., J. Lamontagne, F. Lu, and T. Block. 2008. Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis. Apoptosis 13:483-494.
23. Lu, X., Y. Lu, R. Geschwindt, R. A. Dwek, and T. M. Block. 2001. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum. DNA Cell Biol. 20:647-656.
24. Lukkonen, A., S. Lintula, K. von Boguslawski, O. Carpen, B. Ljungberg, G. Landberg, and U. H. Stenman. 1999. Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int. J. Cancer 83:486-490.
25. Mahrus, S., and C. S. Craik. 2005. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells. Chem. Biol. 12:567-577.
26. McCaffrey, A. P., H. Nakai, K. Pandey, Z. Huang, F. H. Salazar, H. Xu, S. F. Wieland, P. L. Marion, and M. A. Kay. 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21:639-644.
27. Mullbacher, A., K. Ebnet, R. V. Blanden, R. T. Hla, T. Stehle, C. Museteanu, and M. M. Simon. 1996. Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. Proc. Natl. Acad. Sci. USA 93:5783-5787.
28. Nicholson, D. W., and N. A. Thornberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299-306.
29. Nunez, G., M. A. Benedict, Y. Hu, and N. Inohara. 1998. Caspases: the proteases of the apoptotic pathway. Oncogene 17:3237-3245.
30. Ogawa, M., T. Shibata, T. Niinobu, K. Uda, N. Takata, and T. Mori. 1988. Serum pancreatic secretory trypsin inhibitor (PSTI) in patients with inflammatory diseases. Adv. Exp. Med. Biol. 240:505-508.
31. Ohmachi, Y., A. Murata, N. Matsuura, T. Yasuda, T. Yasuda, M. Monden, T. Mori, M. Ogawa, and K. Matsubara. 1993. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int. J. Cancer 55:728-734.
32. Ohmachi, Y., A. Murata, T. Yasuda, K. Kitagawa, S. Yamamoto, M. Monden, T. Mori, N. Matsuura, and K. Matsubara. 1994. Expression of the pancreatic secretory trypsin inhibitor gene in the liver infected with hepatitis B virus. J. Hepatol. 21:1012-1016.
33. Pardo, J., A. Bosque, R. Brehm, R. Wallich, J. Naval, A. Mullbacher, A. Anel, and M. M. Simon. 2004. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J. Cell Biol. 167:457-468.
34. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
35. Ren, G.-L., X.-F. Bai, Y. Zhang, H.-M. Chen, C.-X. Huang, P.-Z. Wang, G.-Y. Li, Y. Zhang, and J.-Q. Lian. 2005. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA. Biochem. Biophys. Res. Commun. 335:1051-1059.
36. Roger, W. 2006. Global challenges in liver disease. Hepatology 44:521-526.
37. Shresta, S., T. A. Graubert, D. A. Thomas, S. Z. Raptis, and T. J. Ley. 1999. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 10:595-605.
38. Stenman, U.-H. 2002. Tumor-associated trypsin inhibitor. Clin. Chem. 48:1206-1209.
39. Thorburn, J., L. M. Bender, M. J. Morgan, and A. Thorburn. 2003. Caspaseand serine protease-dependent apoptosis by the death domain of FADD in normal epithelial cells. Mol. Biol. Cell 14:67-77.
40. Tomita, N., S. Doi, M. Higashiyama, H. Morimoto, M. Murotani, Y. Kawasaki, T. Monden, T. Shimano, A. Horii, H. Yokouchi, et al. 1990. Expression of pancreatic secretory trypsin inhibitor gene in human colorectal tumor. Cancer 66:2144-2149.
41. Tonouchi, A., M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, M. Kato, Y. Nimura, K. Iwase, T. Hiwasa, N. Seki, M. Takiguchi, and M. Miyazaki. 2006. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection. Am. J. Gastroenterol. 101:1601-1610.
42. Tsuzuki, S., Y. Kokado, S. Satomi, Y. Yamasaki, H. Hirayasu, T. Iwanaga, and T. Fushiki. 2003. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A. Biochem. J. 372:227-233.
43. Uda, K.-I., A. Murata, J.-I. Nishijima, S. Doi, N. Tomita, M. Ogawa, and T. Mori. 1994. Elevation of circulating monitor peptide/pancreatic secretory trypsin inhibitor-I (PSTI-61) after turpentine-induced inflammation in rats: hepatocytes produce it as an acute phase reactant. J. Surg. Res. 57:563-568.
44. Xiao-Nan Zhang, W. X., J.-D. Wang, Y.-W. Hu, L. Xiang, and Z.-H. Yuan. 2004. siRNA-mediated inhibition of HBV replication and expression. World J. Gastroenterol. 10:5.
45. Yasuda, T., M. Ogawa, A. Murata, Y. Ohmachi, T. Yasuda, T. Mori, and K. Matsubara. 1993. Identification of the IL-6-responsive element in an acute-phase-responsive human pancreatic secretory trypsin inhibitor-encoding gene. Gene 131:275-280.